Regional Suppliers and Manufacturers Show Interest To Oncology Drug Supply To Moscow

Moscow is transitioning to new treatment standards in oncology enabling Moscow medical facilities to autonomously procure drugs for immune and target therapies. The Moscow government has provided over RUR 8 bn for this purpose in 2019. Over 400 drug manufacturers and suppliers from different Russian regions have been invited to participate in chemotherapeutic drug supply auctions.